[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Salisbury et al., 2011 - Google Patents

Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes

Salisbury et al., 2011

View PDF
Document ID
15129792392960595237
Author
Salisbury A
Kosiborod M
Amin A
Reid K
Alexander K
Spertus J
Masoudi F
Publication year
Publication venue
The American journal of cardiology

External Links

Snippet

New-onset, hospital-acquired anemia (HAA) during acute myocardial infarction (AMI) is independently associated with poor outcomes. The patterns of recovery from HAA after AMI and their association with mortality and health status are unknown. In the prospective 24 …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Amin et al. The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality
Lund et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction
Berger et al. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project
Allen et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure
Salisbury et al. Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes
Morrow et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy
Salisbury et al. Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction
Berg et al. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials
Stähli et al. Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes
Schenkeveld et al. Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention
Palmerini et al. Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial
Kwok et al. Relation of frailty to outcomes in patients with acute coronary syndromes
Roe et al. Documented traditional cardiovascular risk factors and mortality in non–ST-segment elevation myocardial infarction
Taskesen et al. Usefulness of mean platelet volume to predict significant coronary artery disease in patients with non–ST-elevation acute coronary syndromes
Luther et al. The relationship between B-type natriuretic peptide and health status in patients with heart failure
Helleberg et al. Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study
Montalescot et al. Relation of timing of cardiac catheterization to outcomes in patients with non–ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational Global Registry of Acute Coronary Events
Nanchen et al. Inflammation during acute coronary syndromes—Risk of cardiovascular events and bleeding
Amraotkar et al. Platelet count and mean platelet volume at the time of and after acute myocardial infarction
Kontos et al. Prognostic value of serial N-terminal pro-brain natriuretic peptide testing in patients with acute myocardial infarction
Cefalo et al. A comparison of patients diagnosed with pulmonary embolism who are≥ 65 years with patients< 65 years
Araújo et al. Quality of care and 30-day mortality of women and men with acute myocardial infarction
Kwok et al. Relation of length of stay to unplanned readmissions for patients who undergo elective percutaneous coronary intervention
Åkerblom et al. Albuminuria and cardiovascular events in patients with acute coronary syndromes: results from the TRACER trial
Raposeiras-Roubín et al. Mortality and cardiovascular morbidity within 30 days of discharge following acute coronary syndrome in a contemporary European cohort of patients: how can early risk prediction be improved? the six-month grace risk score